PTLA
Portola Pharmaceuticals, Inc.
NasdaqGS
People also watch:OPHTPTCTXLRNRLYPPRTA
24.200.27 (1.13%)

After hours: 24.320.12 (0.50%) as of 5:43 PM EDT

Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
1d
Prev Close23.93
Open24.11
Bid23.05 x 300
Ask24.50 x 100
52wk Range18.20 - 57.96
Day's Range23.61 - 24.40
Volume410,082
Avg Vol (3m)631,998
As of 4:00 PM EDT. Market closed.
  • Motley Fool5 hours ago

    These 3 Biotechs Have Automatic Demand

    Building up the sales numbers for a new drug isn't always easy, but these biotechs offer great examples of predictable marketing success.

  • Forbesyesterday

    Six Major Biotech Acquisitions You Could See in 2016 (Part 2)

    Is this the best time in a long time to be buying biotech stocks now that their lagging performance has made them relatively undervalued to other sectors? Todd Hagopian is buying because he believes the biotech industry is ripe for acquisitions as large, cash-flow rich drug companies look for promising new products. This is the 2nd in a three-part series focusing on potential mergers and acquisitions in the biotech sector.